Novel therapies for chronic myelogenous leukemia
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (5) , 543-556
- https://doi.org/10.1016/s0301-472x(01)00633-6
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 MiceAntisense and Nucleic Acid Drug Development, 1997
- Inhibition of Grb2 and Crkl Proteins Results in Growth Inhibition of Philadelphia Chromosome Positive Leukemic CellsBiochemical and Biophysical Research Communications, 1997
- Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude MiceAntisense and Nucleic Acid Drug Development, 1997
- Transduction of hematopoietic stem cells in humans and in nonhuman primatesThe International Journal of Cell Cloning, 1997
- Regulation of Bcl-2 gene expression by BCR-ABL is mediated by RasJournal of Molecular Biology, 1997
- Structure-function relationships of hammerhead ribozymes: from understanding to applicationsTrends in Biotechnology, 1995
- Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAsFEBS Letters, 1994
- Generation of Donor-Derived Antileukemic Cytotoxic T-Lymphocyte Responses for Treatment of Relapsed Leukemia After Allogeneic HLA-Identical Bone Marrow TransplantationJournal of Immunotherapy, 1993
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979